The Dow Jones projected a 548-point gain Monday as markets cheered positive vaccine data from a drug company called Moderna (NASDAQ: MRNA).
Plus, Federal Reserve Chair Jerome Powell presented an optimistic outlook for the U.S. economy on 60 minutes last night.
Here's everything moving the Dow today.
The Dow Jones added 300 points out the gate this morning as governors draw closer to carrying out plans to reopening their economies.
The uptick comes despite growing unemployment numbers, which we cover below.
Plus: the latest coronavirus numbers and a surge in stationary bike sales moving the Dow today.
Read on for details.
The Dow Jones faces more resistance today.
Markets had a rough start to the second quarter in response to the coronavirus outbreak, and it does not look like it's getting much better.
We don't know how long this will last, but the unemployment numbers show we're not over the hill yet.
Today, we'll discuss what you need to know moving forward.
The Dow sank 600 points when news of coronavirus first began circulating.
Though it's regained some of those losses, the market may still hurt for a time.
However, there are a few biotech stocks charged with seeking out a vaccine that could pop over the next year.
In fact, our best biotech stock offers 182% upside potential.
The Dow Jones Industrial Average will rally Wednesday as investors continue to monitor the latest round of earnings reports.
Read on to see who's due to report.
Plus: It's the start of the second day of the World Economic Forum in Davos, Switzerland.
More on how this will affect the Dow today as well...
